ChengDa Pharmaceuticals Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 305.65 million compared to CNY 289.86 million a year ago. Revenue was CNY 305.65 million compared to CNY 289.86 million a year ago.

Net income was CNY 92.05 million compared to CNY 70.5 million a year ago. Basic earnings per share from continuing operations was CNY 0.6119 compared to CNY 0.6076 a year ago. Diluted earnings per share from continuing operations was CNY 0.6119 compared to CNY 0.6076 a year ago.